Amanda S Joyner Selected Research

5- ((4- (5- (7,7- dimethyl- 1,6- dioxaspiro(2.5)octan- 5- yl)- 3- methylpenta- 2,4- dien- 1- yl)cyclohexyl)amino)- 5- oxopent- 3- en- 2- yl methylcarbamate

8/2015

Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amanda S Joyner Research Topics

Disease

3	Neoplasms (Cancer) 08/2015 - 05/2005

Drug/Important Bio-Agent (IBA)

1	5- ((4- (5- (7,7- dimethyl- 1,6- dioxaspiro(2.5)octan- 5- yl)- 3- methylpenta- 2,4- dien- 1- yl)cyclohexyl)amino)- 5- oxopent- 3- en- 2- yl methylcarbamateIBA 08/2015
1	Biological ProductsIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 05/2005
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2005

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 08/2015